Scarica l'app Stockscreener
1.06
0.95%
0.01
Dopo l'orario di chiusura:
1.09
0.03
+2.83%
Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie
Tenaya Therapeutics announces option repricing to retain staff - Investing.com
Here's Why Tenaya Therapeutics (NASDAQ:TNYA) Must Use Its Cash Wisely - Simply Wall St
Tenaya Therapeutics (TNYA) Stock Price, News & Analysis - MarketBeat
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Shares Sold by Jane Street Group LLC - Defense World
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $17.33 Average PT from Brokerages - MarketBeat
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) PT at $17.33 - Defense World
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Short Interest Update - MarketBeat
HC Wainwright Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA) - MarketBeat
Tenaya advances gene therapies for heart conditions By Investing.com - Investing.com Canada
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones - GlobeNewswire
Tenaya advances gene therapies for heart conditions - Investing.com
Tenaya Therapeutics Advances Gene Therapy Programs with Promising TN-201 Trial Progress - StockTitan
Analysts Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Price Target at $17.33 - MarketBeat
Geode Capital Management LLC Increases Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Things To Consider Before Buying Tenaya Therapeutics Inc (NASDAQ: TNYA) - Stocks Register
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy - BioWorld Online
Largest borrow rate increases among liquid names - TipRanks
State Street Corp Purchases 9,506 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics: TN-201 Isn't The Only Shot On Goal Targeting Heart Disease (TNYA) - Seeking Alpha
Short Interest in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Grows By 18.8% - MarketBeat
Reviewing Caribou Biosciences (NASDAQ:CRBU) & Tenaya Therapeutics (NASDAQ:TNYA) - Defense World
XTX Topco Ltd Has $95,000 Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) Earns Buy Rating from Chardan Capital - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) Earns “Buy” Rating from HC Wainwright - Defense World
Tenaya Therapeutics (NASDAQ: TNYA) Senior Vice President Chihiro Saito Resigns: 8-K Filing - Defense World
Tenaya Therapeutics stock backed by H.C. Wainwright on TN-401 safety and protein expression gains - Investing.com
Tenaya Therapeutics (NASDAQ:TNYA) Receives "Buy" Rating from Chardan Capital - MarketBeat
Tenaya Therapeutics (NASDAQ:TNYA) Given "Buy" Rating at HC Wainwright - MarketBeat
Tenaya Stock Crashes as Cardio Gene Therapy Delivers Underwhelming Early-Stage Data - BioSpace
Tenaya Therapeutics stock hits 52-week low at $1.49 By Investing.com - Investing.com South Africa
Contrasting Tenaya Therapeutics (NASDAQ:TNYA) and Vaxart (NASDAQ:VXRT) - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) & Big Cypress Acquisition (OTCMKTS:BCYP) Critical Comparison - Defense World
Tenaya reports positive early data on heart gene therapy By Investing.com - Investing.com Australia
Tenaya stock in selloff on gene therapy data (TNYA:NASDAQ) - Seeking Alpha
Tenaya Therapeutics announces executive departure - Investing.com
Tenaya Therapeutics stock hits 52-week low at $1.49 - Investing.com
Tenaya Therapeutics Reports Promising TN-201 Trial Results - TipRanks
Tenaya Therapeutics’ Senior VP Resigns for New Opportunity - TipRanks
Tenaya reports positive early data on heart gene therapy - Investing.com
Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy - GlobeNewswire
Tenaya's Gene Therapy Shows Promise in Early Heart Disease Trial DataKey Clinical Results - StockTitan
Crude Oil Down Over 1%; US Industrial Production Declines In November - Benzinga
Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024 - The Manila Times
Tenaya Therapeutics to Unveil Groundbreaking Gene Therapy Data for Heart Disease Treatment - StockTitan
Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 - GlobeNewswire
Fmr LLC Raises Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Around the Helix: Cell and Gene Therapy Company Updates – December 11, 2024 - CGTLive™
Tenaya Therapeutics' SWOT analysis: gene therapy stock faces pivotal catalysts - Investing.com
5.49%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):